Training Program in Drug Dependence Epidemiology

描述（由申请人提供）：该提案是为位于密歇根州立大学人类医学院流行病学系的NIH/NIDA药物依赖流行病学培训计划（DDETP）提供为期5年的更新机构T32 NRSA支持。DDETP的创始人/培训项目主任是James C. (Jim) Anthony教授，他在2003年至2010年的NIDA K05高级科学家工作包括根据他在约翰霍普金斯大学（1990-2003）成功的DDETP模型创建了MSU DDETP，并因此获得了三个导师奖。该项目由流行病学教授Naomi Breslau领导，密歇根州立大学的跨学科教师代表流行病学/生物统计学、定量方法论、临床科学/治疗学、行为遗传学、临床前/临床药理学以及相关领域（如社会学、社会工作、家庭治疗）。DDETP的主要目标是增加相关领域中精通定量的流行病学家和研究人员的数量和质量，他们的职业承诺是NIDA的使命，即预防和控制药物依赖综合征和相关的精神活性药物使用的疑似危害。建议的3名NIDA博士预科学员首先完成2-3年的研究学徒课程，通过资格考试以建立博士候选人资格，然后完成2-3年的研究，然后完成一篇专著长度的论文，代表新的科学证据的重大贡献，需要在NIDA流行病学研究背景下进行统计估计或正式的假设检验。建议的3名0级、3级和7级博士后学员完成药物依赖流行病学研究生研究培训的个性化计划，持续时间为1-3年（主要为1-2年），在NIDA研究中有更多的时间平衡。这两种类型的受训者都完成了必要的诚信和道德培训，并努力在该领域的期刊上汇集第一作者和合作作者的文章，草稿

DESCRIPTION (provided by applicant): This proposal is for 5 years of renewed institutional T32 NRSA support for the NIH/NIDA Drug Dependence Epidemiology Training Program (DDETP) located within Michigan State University College of Human Medicine Department of Epidemiology. DDETP founder/training program director is Professor James C. (Jim) Anthony, whose NIDA K05 Senior Scientist work between 2003 and 2010 included creation of the MSU DDETP, based upon his model for a successful DDETP at Johns Hopkins University (1990-2003), for which he received three mentoring awards. Also leading the program is Epidemiology Professor Naomi Breslau, and there is an interdisciplinary MSU faculty who represent epidemiology/biostatistics, quantitative methodology generally, clinical sciences/therapeutics, behavioral genetics, preclinical/clinical pharmacology, and allied fields (e.g., sociology, social work, family therapy). The main DDETP goal is to increase the number and quality of quantitatively adept epidemiologists and researchers in allied fields whose career commitment is toward NIDA's mission to prevent and control drug dependence syndromes and related suspected hazards of psychoactive drug use. The proposed 3 NIDA predoctoral trainees first complete 2-3 years of coursework with research apprenticeships, pass qualifying exams to establish candidacy for the PhD, and then complete 2-3 years of research before final defense of a monograph-length dissertation representing significant contributions of new scientific evidence that requires statistical estimation or formal hypothesis-testing in the NIDA epidemiology research context. The proposed 3 postdoctoral trainees at Levels 0, 3, & 7 complete an individualized program of postgraduate research training in drug dependence epidemiology, of 1-3 years duration (mostly 1-2 years), with a greater balance of time in NIDA research. Both types of trainees complete required integrity and ethics training, and work to assemble a portfolio of first-authored and co-authored articles in journals of the field, drafts of their own investigator-initiated NIDA grant award applications, and K-type career development plans, when appropriate. The program plan is designed to meet six challenges: (1) enhancing diversity outreach, (2) greater integration with MSU's new NIH clinical translational research and training initiatives, including HIV/AIDS research, (3) new educational modules on project management and on non-academic career paths toward health science and federal agency administration, small business and industry research (e.g., NIDA SBIR & STTR), (4) use of NIH and NIDA online career tracking programs, as well as online surveys to assess the mentoring process, (5) forging new solutions to a recently appreciated 'drift away' process that now detracts from post-program success in a competitive research funding environment, and (6) cultivation of a new generation of the program's Primary Advising Faculty (PAF) members in order to promote the success of the program during the proposed renewal award period and beyond.